Millenium cement restrictor:
This article was originally published in Clinica
Executive Summary
Millenium Biologix has received US FDA 510(k) clearance to market its Microporous Skelite resorbable cement restrictor for use in orthopaedic surgeries such as those involving the femoral and tibial canals in hip stem and total knee replacements. The implant is the first device based on the firm's Microporous Skelite technology to reach the market; the technology enables the development of specialised synthetic bone graft implants with greater compressive strength and impact resistance, claims the Kingston, Ontario firm.